SCHEMBL2190600

SCHEMBL2190600

Cn1cnc(-c2nccc(N)n2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 2/20 0.42
CYP2C19 P33261 2/20 0.42
CYP2E1 P05181 1/20 0.42
CYP2A6 P11509 1/20 0.42
CYP2B6 P20813 1/20 0.42
KDM2B Q8NHM5 1/20 0.42
PHF8 Q9UPP1 1/20 0.42
KDM5A P29375 1/20 0.41
KDM5B Q9UGL1 1/20 0.41
ADORA2A P29274 1/20 0.40
ADORA1 P30542 1/20 0.40
LRRK2 Q5S007 1/20 0.39
MAPT P10636 2/20 0.35
IRAK4 Q9NWZ3 2/20 0.35
GUCY1B2 O75343 1/20 0.34
GUCY1A2 P33402 1/20 0.34
OPRK1 P41145 1/20 0.34
GUCY1A1 Q02108 1/20 0.34
GUCY1B1 Q02153 1/20 0.34
KDM4E B2RXH2 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14031727 0.77 CYP2E1 (0.41) CYP2C9CYP2C19CYP2E1CYP2A6CYP2B6
SCHEMBL16547507 0.75 CYP2C9 (0.52) CYP2C9CYP2C19CYP2E1CYP2A6CYP2B6
SCHEMBL24921816 0.73 CYP2E1 (0.41) CYP2C9CYP2C19CYP2E1CYP2A6CYP2B6
SCHEMBL27754726 0.72 HSP90AA1 (0.42) IRAK4KDM4EMEN1NOS3NOS1
SCHEMBL14844627 0.71 LRRK2 (0.48) CYP2C9CYP2C19CYP2E1CYP2A6CYP2B6
SCHEMBL23753887 0.71 MTOR (0.43) ADORA2ALRRK2IRAK4MKNK1MKNK2
SCHEMBL13729880 0.71 CYP2E1 (0.39) CYP2C9CYP2C19CYP2E1CYP2A6CYP2B6
SCHEMBL19381554 0.70 GUCY1B2 (0.36) IRAK4GUCY1B2GUCY1A2OPRK1GUCY1A1
SCHEMBL30884643 0.70 ALDH1A1 (0.46) MAPTIRAK4KDM4EMEN1NOS3
SCHEMBL29195175 0.70 ALDH1A1 (0.46) MAPTIRAK4KDM4EMEN1NOS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2346859-A1 HETEROCYCLIC JAK KINASE INHIBITORS AstraZeneca AB (SE) 2011-07-27 EP disclosed